U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598383) titled 'A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis' on May 14.

Brief Summary: This is a multicenter, randomized, double-blind, vehicle controlled phase II clinical study to evaluate the efficacy and safety of VC005 gel in adult subjects with mild to moderate atopic dermatitis

Study Start Date: May 30

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis

Intervention: DRUG: VC005 group

VC005 group with Local topical application

DRUG: VC005 Placebo group

VC005 Placebo group with Local to...